Previous Close | 6.69 |
Open | 6.71 |
Bid | 7.12 x 0 |
Ask | 7.28 x 0 |
Day's Range | 6.71 - 7.29 |
52 Week Range | 3.70 - 10.80 |
Volume | |
Avg. Volume | 66,529 |
Market Cap | 135.64M |
Beta (5Y Monthly) | 0.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.89 |
Earnings Date | Mar 19, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.76 |
MILAN, April 08, 2024--Newron presents existing evenamide study 014/015 data and future clinical development outlook for evenamide at 2024 SIRS Congress in Florence, Italy
MILAN, March 19, 2024--Newron Pharmaceuticals announces 2023 year-end financial results and provides 2024 business outlook.
MILAN, March 15, 2024--Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement